NUEVOLUTION A/S: Financial statements 2023
CVR: 26029708
NUEVOLUTION A/S (CVR 26029708) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 77,164,000 and a net result of DKK -36,208,000 compared with DKK -28,120,000 the year before. That is an increase of 12.7% compared with the year before. The profit margin was -46.9%. Equity amounted to DKK 68,122,000. The solvency ratio was 51.9%. The company had 69 employees in the financial year.
- Revenue
- 77,164,000 kr.
- Profit/Loss
- -36,208,000 kr.
- Equity
- 68,122,000 kr.
- Total Assets
- 131,377,000 kr.
- Employees
- 69
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 77.2 mio. | - | -36.2 mio. | 68.1 mio. | 69 |
| 2022 | 68.5 mio. | - | -28.1 mio. | 104.3 mio. | 63 |
| 2021 | 162.3 mio. | - | 63 mio. | 132.4 mio. | 56 |
| 2020 | 37 mio. | - | -33.5 mio. | 69.5 mio. | 54 |
| 2019 | 17.4 mio. | - | -76.3 mio. | 1.8 mio. | 49 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 15, 2023, is registered as an owner of NUEVOLUTION A/S with an ownership share of 100%.
NUEVOLUTION A/S has published its annual report for 2022. Revenue came to DKK 68,498,000, and the net result was DKK -28,120,000.
About NUEVOLUTION A/S
NUEVOLUTION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CHEMGENE ApS. The management consists of Thomas Franch. The company is owned by Amgen, Inc.. The company has 59 employees. In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. Equity amounted to DKK 89,493,000.
